TrialDrug design, development and therapy2026

First-in-Human Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Ascending Oral Doses of BIIB091, an Oral BTK Inhibitor, in Healthy Adult Participants.

Hui-Hsin Tsai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.